# Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome

> **NCT02022241** · NA · UNKNOWN · sponsor: **Chenshiling** · enrollment: 80 (estimated)

## Conditions studied

- Infertility and at High Risk of OHSS

## Interventions

- **DRUG:** triptorelin

## Key facts

- **NCT ID:** NCT02022241
- **Lead sponsor:** Chenshiling
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07
- **Primary completion:** 2015-12
- **Final completion:** 2016-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2013-12-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02022241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02022241, "Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02022241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*